<?xml version="1.0" encoding="UTF-8"?>

<rss version="0.91">

<channel>
<title>China Pharma Update</title>
 <link>http://www.eastcity.com/ChinaPharmaUpdate.html</link>
<description>Here is your latest content from China Pharma Update</description>
<language>en-us</language>

<pubDate>Wed, 20 Aug 2003 13:51:55 GMT</pubDate>

<item>
<title>Vitamin C Popular</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=176</link>
<description></description>
</item>

<item>
<title>Three MNCs Compete for China's Market of Vaccines</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=177</link>
<description></description>
</item>

<item>
<title>Pharmaceutical Companies Compete for RMB10 Billion Business Opportunity</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=178</link>
<description></description>
</item>

<item>
<title>Six Regional-Standard Antibiotics Banned</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=179</link>
<description></description>
</item>

<item>
<title>Eli Lilly Cooperates With HiSun to Treat TB</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=180</link>
<description></description>
</item>

<item>
<title>Imported and JV Medicines Sell Well in China</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=181</link>
<description></description>
</item>

<item>
<title>Solid Establishment, Energetic Expansion</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=182</link>
<description></description>
</item>

<item>
<title>Eighty-Three Budget Terms That Do Away With Wasteful Public &quot;Expenses&quot;</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=159</link>
<description></description>
</item>

<item>
<title>Type II Diabetes Under Discussion</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=160</link>
<description></description>
</item>

<item>
<title>Eli Lilly Donations Delivered to China Yesterday</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=161</link>
<description></description>
</item>

<item>
<title>Cooperative Campaign Against MRD-TB Offers Business Opportunities for Chinese Drug Maker</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=162</link>
<description></description>
</item>

<item>
<title>Omron Attempts to Create Second Omron in China</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=163</link>
<description></description>
</item>

<item>
<title>After Compound Vitamins Become Popular</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=143</link>
<description></description>
</item>

<item>
<title>Pfizer Donates $200,000 to Support China's Fight Against SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=144</link>
<description></description>
</item>

<item>
<title>Pharmaceutical Companies Competing on Market of SARS Vaccines</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=145</link>
<description></description>
</item>

<item>
<title>Hotline Launched to Help Diabetic Patients Treat SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=146</link>
<description></description>
</item>

<item>
<title>When Can R&amp;D Help Chinese Pharmaceutical Companies Succeed on Global Market?</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=147</link>
<description></description>
</item>

<item>
<title>Bayer Troubled by Accusations it Sold &quot;Tainted Blood&quot;</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=148</link>
<description></description>
</item>

<item>
<title>Be Happy at Fall in SARS Cases; Be Vigilant Against Recurrence of SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=128</link>
<description></description>
</item>

<item>
<title>Analysis of Drug Retail Market in March</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=129</link>
<description></description>
</item>

<item>
<title>When Can Biotechnology Be Relied on to Save Lives?</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=130</link>
<description></description>
</item>

<item>
<title>China Welfare Institute Holds &quot;Big Hand Holding Small Hand&quot; Activity; Young Pioneer Members Receive &quot;Household Manual for SARS Prevention&quot;</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=131</link>
<description></description>
</item>

<item>
<title>US Drug Maker Suspected of Selling Lethal Drug</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=132</link>
<description></description>
</item>

<item>
<title>Shanghai Roche Donates RMB10 Million to Medical Staff Fighting SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=112</link>
<description></description>
</item>

<item>
<title>Foreign Investment in Beijing's Chaoyang District Increases Despite SARS Crisis</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=113</link>
<description></description>
</item>

<item>
<title>Philips China Donates Medical Equipment and Cash Worth RMB4.3 Million to Fight SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=114</link>
<description></description>
</item>

<item>
<title>Summary of Seminar on &quot;Three R&quot; Principle for Preventing In-Hospital Infection of Cefepime</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=115</link>
<description></description>
</item>

<item>
<title>Enterprises Located in Minxing Development Zone Develop Fast Under Pressure</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=116</link>
<description></description>
</item>

<item>
<title>Gatifloxacin (Tequin) Features Outstanding PK/PD</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=117</link>
<description></description>
</item>

<item>
<title>Antonio Chow: Roche Operations Prevail in SARS Period</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=97</link>
<description></description>
</item>

<item>
<title>Calcium Supplements Approved as Medicine Sell Well</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=98</link>
<description></description>
</item>

<item>
<title>Competition in R&amp;D for Vaccines</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=99</link>
<description></description>
</item>

<item>
<title>Gatifloxacin: New Product, Great Potential</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=100</link>
<description></description>
</item>

<item>
<title>Roche Assists Hospitals Treating SARS Patients</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=101</link>
<description></description>
</item>

<item>
<title>Handling Exit-Entry Procedures Online</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=102</link>
<description></description>
</item>

<item>
<title>Four Approaches to Discovery of Vaccine for SARS</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=80</link>
<description></description>
</item>

<item>
<title>Johnson &amp; Johnson Becomes Second Largest Shareholder</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=81</link>
<description></description>
</item>

<item>
<title>No State Boundary for Love</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=82</link>
<description></description>
</item>

<item>
<title>These Drugs Are Banned</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=83</link>
<description></description>
</item>

<item>
<title>Network of ADR Monitoring Completed Nationwide</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=62</link>
<description></description>
</item>

<item>
<title>Avelox: New Medicine</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=63</link>
<description></description>
</item>

<item>
<title>Health Products Expect Boom</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=64</link>
<description></description>
</item>

<item>
<title>Three Kinds of General Hormone Popular</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=65</link>
<description></description>
</item>

<item>
<title>China to Open Drug Distribution Market Next Year</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=66</link>
<description></description>
</item>

<item>
<title>Annual Medical Costs for Treatment Complaints of Type II Diabetes Approach to RMB16.5 Billion in China Every Year</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=67</link>
<description></description>
</item>

<item>
<title>Develche Follows Example of Gome to Survive Challenge After China Opens Drug Distribution Sector</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=46</link>
<description></description>
</item>

<item>
<title>Booming Period of Medicine Logistics Industry</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=48</link>
<description></description>
</item>

<item>
<title>Pharmaceutical Enterprises to Renew Production Permits</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=49</link>
<description></description>
</item>

<item>
<title>Second CAS-Bayer Research Funds Awarded in Beijing</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=45</link>
<description></description>
</item>

<item>
<title>Drug Retailers Compete in Services</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=47</link>
<description></description>
</item>

<item>
<title>Domestic Pharmaceutical Enterprises Dominate Low-End Market</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=23</link>
<description></description>
</item>

<item>
<title>China to Open Drug Distribution Market Next Year</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=27</link>
<description></description>
</item>

<item>
<title>Novo Nordisk Invests RMB20 Million to Foster Future Market</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=24</link>
<description></description>
</item>

<item>
<title>Imported, JV-Made Medicines Hold 50% of Share</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=13</link>
<description></description>
</item>

<item>
<title>SETC Issues Guide for Pharmaceutical Industry</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=35</link>
<description></description>
</item>

<item>
<title>Domestic and Foreign Pharmaceutical Companies Engaged in Fierce Competition</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=36</link>
<description></description>
</item>

<item>
<title>Christian Velmer Replaces ZHUANG Xiangxing as President of Xi'an Janssen</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=14</link>
<description></description>
</item>

<item>
<title>What Are CROs Doing in China?</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=26</link>
<description></description>
</item>

<item>
<title>&quot;Guidance on Standardized Prevention and Treatment of Diabetes&quot; to be Released</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=15</link>
<description></description>
</item>

<item>
<title>Safety Appraisal of New Drugs Needs International Approval</title>
<link>http://www.eastcity.com/news.php?task=view&amp;newsID=25</link>
<description></description>
</item>

</channel>
</rss>
